Other
Artidis
is a biotech company that develops and commercializes nanomechanical biomarkers for the treatment of cancer... Read moreArtidis
is a biotech company that develops and commercializes nanomechanical biomarkers for the treatment of cancer... Read moreNews
Nov 08, 2024
FinanzNachrichten
Artidis: Artidis AG: ARTIDIS announces publication demonstrating the nanomechanical signature of response to low-dose radiotherapy followed by CAR T cell therapy in solid tumors.
Nov 02, 2023
FinanzNachrichten
Artidis: Artidis AG: ARTIDIS Launches Groundbreaking ANGEL Study With Over 2,700 Participants: Transforming Breast Cancer Diagnosis and Personalized Therapy Optimization at the Patient's Bedside
Oct 03, 2022
BioSpace
Artidis: MD Anderson and ARTIDIS Announce Strategic Alliance to Advance Nanomechanical Technology Platform for Optimizing Cancer Treatment
May 05, 2021
FE Investegate
Artidis: Artidis AG : ARTIDIS enters clinical collaboration to investigate nanomechanical profiling as a novel diagnostic and treatment optimization approach in patients with lung cancer
Feb 10, 2021
startupticker ch
Artidis: HEMEX closes an oversubscribed series c financing round
Dec 21, 2020
FinanzNachrichten
Artidis: Artidis AG: ARTIDIS investigates nanomechanical tissue signature to improve response to radio/immuno-therapy in lung cancer
Oct 27, 2020
MedCity News
Artidis: Swiss startup betting on nanotechnology to speed cancer diagnosis
Jun 22, 2020
startupticker
ARTIDIS: Good news for cancer patients
Jun 21, 2020
FE Investegate
ARTIDIS: Artidis AG : ARTIDIS First Prospective Study, "NANO", Evaluating its Nanotechnology Platform Based on a Novel Nanomechanical Biomarker in Breast Cancer Meets Primary Endpoint
Dec 05, 2019
startupticker ch
ARTIDIS: ARTIDIS Raises CHF 8.8 Million in Seed Financing
Artidis Competitors
1
2
3
4
5
6
7